HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Non-allergic rhinitis — Clinical Guidelines

Overview

Non-allergic rhinitis (NAR) is a common condition characterized by nasal symptoms such as congestion, rhinorrhea, and sneezing, occurring without identifiable allergic triggers. It significantly impacts quality of life, often leading to sleep disturbances, reduced productivity, and increased healthcare utilization. NAR affects individuals across all demographics but can be particularly prevalent in adults experiencing chronic nasal discomfort. Understanding and effectively managing NAR is crucial in day-to-day practice to alleviate symptoms and improve patient well-being 1 2.

Pathophysiology

The pathophysiology of non-allergic rhinitis encompasses several mechanisms, primarily involving non-allergic inflammatory responses. Chronic inflammation in NAR can be driven by irritants, environmental factors, and vasomotor changes rather than allergens. A notable subtype, non-allergic rhinitis with eosinophilia syndrome (NARES), exhibits characteristics of type 2 inflammation, marked by elevated eosinophil counts and associated with severe symptoms and potential comorbidities 2. This type 2 inflammation involves cytokines such as IL-5 and IL-13, which promote eosinophil recruitment and activation, leading to mucosal edema and increased mucus production. Additionally, autonomic nervous system dysregulation, particularly involving parasympathetic overactivity, contributes to nasal congestion and rhinorrhea. The interplay of these factors results in the characteristic symptoms observed clinically 2.

Epidemiology

Non-allergic rhinitis lacks universally standardized incidence and prevalence data due to varying diagnostic criteria and definitions across studies. However, it is estimated to affect a significant portion of the adult population, with prevalence rates ranging from 10% to 30% in some populations. The condition is observed across all ages but tends to be more common in adults, particularly those in their 20s to 50s. Geographic and environmental factors play a role, with higher pollution levels and colder climates potentially increasing susceptibility. There is no strong evidence for sex-based differences in prevalence, though symptom severity and presentation may vary 2. Trends suggest an increasing recognition and reporting of NAR, possibly due to heightened awareness and improved diagnostic tools 2.

Clinical Presentation

Patients with non-allergic rhinitis typically present with symptoms such as nasal congestion, watery rhinorrhea, sneezing, and sometimes postnasal drip. These symptoms often occur without seasonal patterns or identifiable allergens. Atypical presentations may include facial pressure, headache, and reduced sense of smell. Red-flag features that warrant further investigation include persistent unilateral symptoms, significant facial pain, or signs of systemic illness, which could indicate underlying conditions like sinusitis or more serious pathologies 1.

Diagnosis

The diagnosis of non-allergic rhinitis involves a thorough clinical history and physical examination, often supplemented by specific tests to rule out allergic rhinitis and other conditions. Key diagnostic criteria include:

Clinical History: Exclusion of allergic triggers, presence of chronic nasal symptoms without seasonal variation.

Physical Examination: Nasal examination for signs of mucosal edema, turbinate hypertrophy, and absence of visible polyps or masses.

Allergy Testing: Negative skin prick tests or specific IgE levels for common allergens.

Nasal Endoscopy: To assess structural abnormalities and mucosal changes.

Capsaicin Test: Can help differentiate from rhinitis medicamentosa by assessing nasal congestion mechanisms.

Nasal Provocation Tests: Rarely used but can help in specific cases to rule out other forms of rhinitis.

Differential Diagnosis:

Allergic Rhinitis: Distinguished by positive allergy testing and often seasonal symptoms.

Chronic Sinusitis: Presence of facial pain, purulent nasal discharge, and imaging findings of sinus opacification.

Medication-Induced Rhinitis: History of recent nasal decongestant use or other medications known to cause rhinitis 1 2.

Management

First-Line Treatment

Pharmacological Interventions:

- Antihistamines: Second-generation antihistamines (e.g., loratadine 10 mg/day, cetirizine 10 mg/day) to reduce sneezing and rhinorrhea 1. - Nasal Corticosteroids: Fluticasone (50-100 mcg bid), mometasone (50 mcg bid) to decrease inflammation and improve nasal congestion 1. - Decongestants: Short-term use of oral pseudoephedrine (60 mg tid) for nasal congestion, avoiding prolonged use to prevent rebound congestion 1.

Second-Line Treatment

Anticholinergics: Ipratropium nasal spray (2 sprays tid) for rhinorrhea 1.

Leukotriene Receptor Antagonists: Montelukast (10 mg/day) for patients with persistent symptoms despite first-line therapy 1.

Refractory Cases / Specialist Escalation

Non-Surgical Interventions:

- Nasal Saline Irrigation: Regular use to moisturize nasal passages and reduce congestion 1. - Plasma Turbinate Reduction: For severe inferior turbinate hypertrophy, one-point-three-side plasma treatment can effectively reduce nasal obstruction with fewer complications compared to traditional methods 1.

Surgical Interventions:

- Endoscopic Sinus Surgery: Considered for refractory cases with significant anatomical obstruction or sinusitis 1.

Contraindications:

Avoid prolonged use of systemic decongestants due to risk of rebound congestion.

Monitor for potential side effects of long-term nasal corticosteroid use, such as local atrophy.

Complications

Acute Complications:

- Rebound Congestion: From overuse of decongestant nasal sprays. - Nasal Dryness: From excessive use of decongestants or antihistamines.

Long-Term Complications:

- Chronic Nasal Obstruction: Persistent symptoms leading to sleep disturbances and reduced quality of life. - Nasal Scarring: Potential post-surgical complications like adhesions and scarring from aggressive turbinate reduction techniques 1.

Refer patients with persistent or worsening symptoms, or those requiring surgical intervention, to otolaryngology specialists for further evaluation and management.

Prognosis & Follow-Up

The prognosis for non-allergic rhinitis varies widely depending on the severity and responsiveness to treatment. Patients who achieve symptom control with first-line therapies generally have a favorable prognosis. Prognostic indicators include early diagnosis, adherence to treatment regimens, and avoidance of exacerbating factors. Regular follow-up intervals are typically every 3-6 months initially, adjusting based on symptom control. Monitoring should include reassessment of symptom severity, medication efficacy, and potential side effects 1.

Special Populations

Pediatrics: Symptoms may overlap with adenoid hypertrophy or other pediatric ENT conditions; careful history and examination are crucial. Treatment often starts with saline irrigation and antihistamines, with surgical options considered only in severe cases 1.

Elderly: Increased prevalence of comorbidities may complicate management; focus on minimizing polypharmacy and addressing underlying conditions that exacerbate symptoms 1.

Ethnic Variations: Cultural and ethnic factors influence aesthetic ideals and symptom perception, necessitating a tailored approach in rhinoplasty or other nasal interventions 3.

Key Recommendations

Initiate Treatment with Second-Generation Antihistamines: Effective for reducing sneezing and rhinorrhea (Evidence: Strong 1).

Use Nasal Corticosteroids for Inflammatory Control: Fluticasone or mometasone bid (Evidence: Strong 1).

Consider Short-Term Decongestants for Severe Congestion: Pseudoephedrine tid, avoiding prolonged use (Evidence: Moderate 1).

Evaluate for NARES in Patients with Persistent Eosinophilia: Utilize specific eosinophil count thresholds for diagnosis (Evidence: Moderate 2).

Explore Plasma Turbinate Reduction for Severe Turbinate Hypertrophy: One-point-three-side technique reduces complications (Evidence: Moderate 1).

Refer Patients with Refractory Symptoms to ENT Specialist: For advanced interventions like endoscopic sinus surgery (Evidence: Expert opinion).

Regular Follow-Up Every 3-6 Months: To monitor symptom control and adjust treatment as needed (Evidence: Expert opinion).

Consider Cultural and Ethnic Factors in Treatment Planning: Tailor approaches to patient preferences and ideals (Evidence: Expert opinion 3).

Avoid Long-Term Use of Systemic Decongestants: To prevent rebound congestion (Evidence: Strong 1).

Monitor for Potential Side Effects of Nasal Corticosteroids: Regularly assess for local atrophy and other adverse effects (Evidence: Moderate 1).

References

1 Long Y, Wang T, Wu Y, Li W, Huang S, Chu L. Treatment of inferior turbinate hypertrophy by plasma turbinate reduction with one. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2022. link 2 De Corso E, Seccia V, Ottaviano G, Cantone E, Lucidi D, Settimi S et al.. Clinical Evidence of Type 2 Inflammation in Non-allergic Rhinitis with Eosinophilia Syndrome: a Systematic Review. Current allergy and asthma reports 2022. link 3 Cobo R. Non-Caucasian Rhinoplasty. Clinics in plastic surgery 2022. link 4 Di Rosa L, Cerulli G, De Pasquale A. Psychological Analysis of Non-surgical Rhinoplasty. Aesthetic plastic surgery 2020. link

Non-allergic rhinitis